Troscriptions

Supplement

Pharmaceutical-grade buccal troches, developed by physicians that leverage novel ingredients such as methylene blue, cordycepin, and agarin to enhance cellular function, stress, sleep, and immune resilience.

Services
  • Troscriptions
Location Dover, DE
About

Troscriptions

Troscriptions is a physician-formulated health optimization company delivering pharmaceutical-grade formulations via buccal troches for rapid, reliable absorption and high patient adherence. Developed by practicing clinicians, our products support mitochondrial function, cognitive performance, stress resilience, sleep, and inflammatory balance—tools practitioners can use now while guiding long-term optimization. No fluff. No guesswork. Just precision formulations designed to help you move patients toward measurable, repeatable physiologic balance — one troche at a time.

What We Offer

Services

Physician-formulated buccal troches for energy, focus, sleep, stress, and immune system optimization using novel compounds like methylene blue, cordycepin, agarin, and more.

Unlock exclusive discounts and offers from Troscriptions and other trusted partners with an SSRP Pro Membership.
What People Say

Testimonials

“Troscriptions has been integral in helping my patients recover from a variety of conditions that have stolen their energy and cognitive capacity. I’m thrilled by how many patients successfully transition off various medications with their help.”

Dr. Stephanie Rimka, DC
Dr. Stephanie Rimka, DC Dr. Stephanie Rimka

“Troscriptions products have been game changing in my clinical practice. Having tried numerous products, Troscriptions is the only brand that consistently receives glowing feedback from patients and truly moves the needle on their health challenges, something in only a few days.”

Dr. Ashley Beckman
Dr. Ashley Beckman Dr. Ashley
Network with our partners

Upcoming Events

View Upcoming Events
EVENT
Grand Rounds
December 4 - 5, 2026

Grand Rounds

Coming Soon
RESOURCES

Join us in breaking down the latest research live.

VIEW ALL
PODCAST
Redox Revolution
Oct 13, 2026
Ep.81 – The Crossover Between Cellular Medicine and Regenerative Aesthetics with Angel Channell
Ep.81 – The Crossover Between Cellular Medicine and Regenerative Aesthetics with Angel Channell

In this episode of Redox Revolution, Dr. Seeds sits down with aesthetician Angela Channel to discuss her approach not only to skin care but overall holistic healing.

Cellular Medicine Foundations
VIDEO
Cellular Medicine Mondays
Oct 12, 2026
Ep. 109 - Anti-Ageing Mini Mastermind Part 2
Preview only
Journal Club – Episode 109

Anti-Aging Mini Mastermind Part 2

In Part 2 of our Anti-Aging Mini Mastermind series, Dr. Seeds explores how PGE2 signaling and cellular metabolism influence inflammation, cognitive function, and aging, connecting foundational research to emerging discoveries in immunometabolism.  (2026 Article) (2021 Article)

Preview Only — Become a member for full access
ARTICLE
William Seeds, MD
Oct 8, 2026
EP2, Tissue-Resident Macrophages, and a New Mechanism of Organ Aging
William Seeds, MD Oct 8, 2026
EP2, Tissue-Resident Macrophages, and a New Mechanism of Organ Aging
Revisiting a Journal Club Article, “Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging.” Science. 2026  Why This Paper Matters Most of the senescence conversation over the past decade has centered on a familiar cast: senescent fibroblasts, endothelial cells, adipocytes, and the drugs designed to clear them. This paper, which I discuss in […]
READ ARTICLE
Healthgevity Oct 2, 2026
Healthgevity Introduces hydraCELL+â„¢, Featuring Formulation IP Developed by the Seeds Foundation for Cellular Research
BREAKING NEWS INTERLAKEN, N.J., [October 2, 2026] — Healthgevity, a practitioner-focused precision longevity nutrition company, announced the launch of hydraCELL+â„¢, a cellular hydration and muscle-support formula built on proprietary formulation IP developed through the Seeds Foundation for Cellular Research and licensed to Healthgevity. The formula reflects the cellular medicine approach advanced by William Seeds, MD, and […]
READ NEWS
ARTICLE
William Seeds, MD
Sep 23, 2026
The Future of Regenerative Medicine May Begin with a Hair Follicle
William Seeds, MD Sep 23, 2026
The Future of Regenerative Medicine May Begin with a Hair Follicle
Why a Plucked Hair Follicle May Matter to the Future of Regenerative Medicine In this article, I return to a study that I discussed in a July Journal Club post. The study, published in Cells in 2024, investigated whether cells obtained from plucked, cryopreserved human hair follicles could be reprogrammed into induced pluripotent stem cells […]
READ ARTICLE
Peptide Therapy Certification 2026
The SSRP Peptide Therapy Certification course gives clinicians, researchers, and other healthcare providers a working method for applying Cellular Medicine principles to patient care through clinical peptide therapy. Across 19 faculty-led lessons, Dr. William Seeds and SSRP faculty, including Siobhan...
19 Lessons
15 hrs 43 min
View Course
SSRP Institute Sep 14, 2026
In Case You Missed it: FDA Approves Mounjaro (tirzepatide) for CVD
HEADLINE SCIENCE [Sept 14, 2026] – On August 28, 2026, the FDA expanded the indication for Mounjaro (tirzepatide), approving the dual GIP/GLP-1 receptor agonist to reduce the risk of major adverse cardiovascular events—including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke—in adults with type 2 diabetes at high cardiovascular risk. The decision makes tirzepatide the […]
READ NEWS
EVENT
Certification
September 10 - 11, 2027
Peptide Therapy Certification 2027
Four Seasons Resort Orlando at Walt Disney World, FL
COMING SOON
Certification
Peptide Therapy Certification 2027
COMING SOON
EVENT
World Congress
June 17 - 19, 2027
Peptide World Congress 2027
Arizona Biltmore, Phoenix, AZ
COMING SOON
World Congress
Peptide World Congress 2027
COMING SOON
EVENT
Mastermind
February 15 - 19, 2027
Fellowship Mastermind Summit 2027
Gansevoort Meatpacking NYC, New York, NY
COMING SOON
Mastermind
Fellowship Mastermind Summit 2027
COMING SOON
EVENT
Grand Rounds
December 4 - 5, 2026
Grand Rounds
Four Seasons Resort and Residences Vail
COMING SOON
Grand Rounds
Grand Rounds
COMING SOON
SSRP Institute Aug 27, 2026
Rasonque: An FDA-Approved Drug to Treat Pancreatic Cancer
HEADLINE SCIENCE [August 27, 2026] – The Food and Drug Administration on Wednesday approved daraxonrasib, sold as Rasonque, for adults with metastatic pancreatic adenocarcinoma, the most common form of pancreatic cancer and one long considered among the hardest to treat. The once-daily tablet, developed by Revolution Medicines, is the first targeted therapy approved for the […]
READ NEWS